🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Registry-study of ELZONRIS in Participants With BPDCN

Recruitingn/aAges 18 Years - anyAllStemline Therapeutics, Inc.
NCT07785154 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The main goal of this registry study is to investigate the effectiveness and safety of tagraxofusp in the treatment of adult participants with BPDCN in the real-world clinical practice setting.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Key Inclusion Criteria: * Diagnosed with BPDCN, confirmed by hematopathology and biomarkers (inclusive of CD123, CD4, and CD56). * Planning to start treatment with tagraxofusp monotherapy for BPDCN at the time of, or within 6 months prior to, informed consent form (ICF) signature or has started treatment. Key Exclusion Criteria: * Currently (or planning to) participating in another study or registry where BPDCN treatment outcomes are reported. * Participating in an interventional clinical trial at the time of ICF signature. * Known allergic reactions to components of tagraxofusp. Note: Other protocol-specified criteria apply.
💊

What it tests

  • Tagraxofusp
📍

Where

41 sites
Medical University Innsbruck
Innsbruck, Austria
Ordensklinikum Linz Krankenhaus der Elisabethinen Linz
Linz, Austria
Salzburg Cancer Research Institute (SCRI)
Salzburg, Austria
Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology
Vienna, Austria
Universitätsklinikum Augsburg
Augsburg, Germany
Hospital Bielefeld
Bielefeld, Germany
Klinikum Chemnitz
Chemnitz, Germany
University Clinic of Frankfurt
Frankfurt, Germany

…and 33 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy